Imatinib and Nilotinib inhibit Bcr–Abl-induced ROS through targeted degradation of the NADPH oxidase subunit p22phox

Authors

Keywords

Journal

Volume 37, Issue 2, Pages 183-189

Publisher

Elsevier BV

Online

2012-12-04

DOI

10.1016/j.leukres.2012.11.003

Discuss science. Find collaborators. Network.

Join a conversation

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now